INR:6936. sports free streaming Xinlitai will take over 2.5 billion anticoagulant drug original drug market New news on the fourth round of national procure ...

It may be rational for the physicians to monitor these drugs frequently, even if monitoring is not needed, to make sure that the patient is compliant.

Investigators believe that this new anticoagulant, named tecarfarin ... making it susceptible to drug–drug and drug–food interactions, and meaning that it produces highly variable clinical ...

INR:0195. pkl 2023 points table Xinlitai will take over 2.5 billion anticoagulant drug original drug market Reduce the risk of death by 31%; Phase 3 clinica ...

Regeneron (NASDAQ:REGN) reported positive Phase 2 data for its thrombosis drug candidates REGN7508 and REGN9933 and plans to ...

Around one hundred people a month in England have avoided a stroke over the last year thanks to a lifesaving NHS rollout of blood thinning medication. Over the last year, one million people with ...

They found this true for antihypertensives, lipid-lowering drugs, oral anticoagulants, and diuretics. However, they found that short-term use of 1 to 4 years of all cardiovascular medication ...